Simultaneous resection of the primary tumour and liver metastases after conversion chemotherapy versus standard therapy in pancreatic cancer with liver oligometastasis: protocol of a multicentre, prospective, randomised phase III control trial (CSPAC-1)

INTRODUCTION: Approximately 50% of pancreatic ductal adenocarcinoma (PDAC) patients are diagnosed with distant metastasis, especially liver metastasis. The current standard treatment for these stage IV patients is palliative chemotherapy. There is increasing agreement that synchronous PDAC and liver...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Miaoyan, Shi, Si, Hua, Jie, Xu, Jin, Yu, Xianjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6924808/
https://www.ncbi.nlm.nih.gov/pubmed/31818843
http://dx.doi.org/10.1136/bmjopen-2019-033452

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6924808/
https://www.ncbi.nlm.nih.gov/pubmed/31818843
http://dx.doi.org/10.1136/bmjopen-2019-033452

Ejemplares similares